Replies to post #101636 on Biotech Values

[jmkobers]

<<The apparent fact that no inspection of Teva's Lovenox manufacturing facilities has occurred to date speaks volumes as to how close the FDA is in approving the Teva's aNDA. >>


Don't confuse one man's opinion with fact. There's a big difference. The longs here would like to believe that is indeed the case, and it is a possibility, but the recent stock action post approval makes a pretty strong case for the opposite. I just cannot come up with any other reason MNTA would be flirting with 16, and acting like it wants to head lower. It's possible that someone knows the real answer, and it's not bullish for MNTA.